VSE Capital Markets

Makers Laboratories Ltd

NSE : Not ListedBSE : 506919ISIN CODE : INE987A01010Industry : Pharmaceuticals - Indian - Formulations

BSE144.00 3.45 (2.45%)

PREV CLOSE (₹) 140.55

OPEN PRICE (₹) 144.00

BUY PRICEN/A

SELL PRICE N/A

VOLUME 361

TODAY'S RANGE (₹)146.00142.05

52 WK RANGE(₹)228.35130.00

NSE

PREV CLOSE( ₹ ) N/A

OPEN PRICE (₹) N/A

BUY PRICE N/A

SELL PRICEN/A

VOLUME N/A

TODAY'S RANGE(₹) N/A

52 WK RANGE (₹)N/A

Stock Summary

MARKET CAP (₹ CR)	82.93
P/E	484.66
BOOK VALUE (₹)	86.91
DIV (%)	0.00
MARKET LOT	1.00

EPS (TTM)	0.29
PRICE/BOOK	1.62
DIV YIELD.(%)	0.00
FACE VALUE (₹)	10.00
DELIVERABLES (%)	NA

Background Information

Incorporation Year	1984
Registered Office	54 D Kandivli Industrial Estat,Charkop Kandivli (West) Mumbai,Maharashtra-400067
Telephone	91-22-2868 8544,
Fax	91-22-2868 8544
Chairman	R K P Verma
Managing Director
Company Secretary	Rinku Kholakiya
Auditor	Natvarlal Vepari & Co
Face Value	10
Market Lot	1
Listing	BSE,
Registrar	Link Intime India Pvt Ltd C-101 247 Park ,L B S Marg ,Vikhroli West ,Mumbai-400083

MF Holdings

Scheme Name	Hold(%)

No Data Available!!!

News & Announcements

Date	News
30-Jun-2022	Makers Laboratories Ltd - Closure of Trading Window
01-Jun-2022	Makers Laboratories Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
27-May-2022	Makers Laboratories reports consolidated net loss of Rs 0.61 crore in the March 2022 quarter
27-May-2022	Makers Laboratories Ltd - Board Meeting Outcome for Makers Q4 FY 2022 - Results

Share Holding

Peer Group

Laurus Labs Ltd 490.75 ( 4.68)	M.Cap (₹ in Cr) 25191.41
Ajanta Pharma Ltd 1183.05 ( -0.66)	M.Cap (₹ in Cr) 15259.07
ERIS Lifesciences Ltd 658.40 ( 2.62)	M.Cap (₹ in Cr) 8724.01
Caplin Point Laboratories Ltd 734.55 ( -0.79)	M.Cap (₹ in Cr) 5612.27
Amrutanjan Health Care Ltd 802.40 ( 0.58)	M.Cap (₹ in Cr) 2332.02

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.